Dissemin is shutting down on January 1st, 2025

Published in

American Association for the Advancement of Science, Science, 6580(375), p. 540-545, 2022

DOI: 10.1126/science.abk1688

Links

Tools

Export citation

Search in Google Scholar

A highly virulent variant of HIV-1 circulating in the Netherlands.

Journal article published in 2022 by Ard van Sighem, M. van der Valk, T. van der Poll, M. van Vugt, M. van Duinen, J. van Eden, A. M. H. van Hes, B. Martinez de Tejada, R. van Houdt, A. van der Plas, M. van den Berge, D. N. J. van den Bersselaar, A. van Eeden, M. E. E. van Kasteren, R. van Erve and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log 10 increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV—CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences—is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination, with increased transmissibility and an unfamiliar molecular mechanism of virulence.